Driving Value-Based Practice Transformation Through Care Management

Why It Matters

By leveraging reimbursable care‑management codes, community oncology clinics can improve outcomes, lower avoidable costs, and position themselves for upcoming value‑based payment models without exposing themselves to downside risk.

Key Takeaways

• Food insecurity affects 17‑55% of US cancer patients, raising mortality
• Care‑management codes (PCM, TCM, PIN) generate fee‑for‑service reimbursement
• Pilot programs show reduced readmissions through timely post‑discharge follow‑up
• Navigators address social determinants, linking patients to meals and transport
• Iterative care‑management eases transition to value‑based models without downside risk

Pulse Analysis

The oncology sector has been grappling with the promise‑and‑peril of value‑based payment models such as the Oncology Care Model and its successor, the Enhancing Oncology Model. While these initiatives aim to align incentives with patient outcomes, they impose heavy administrative burdens and financial downside risk that many community practices cannot shoulder. As a result, a growing number of clinics are seeking alternative pathways that preserve the core goal—better health results at lower cost—while operating within existing fee‑for‑service contracts. Care‑management programs provide that bridge, offering structured, reimbursable services that target the social determinants of health often overlooked in traditional oncology care.

Principal Care Management (PCM), Transitional Care Management (TCM), and Principal Illness Navigation (PIN) each focus on a distinct facet of the patient journey. PCM rewards proactive outreach and time‑based interactions, TCM compensates for rapid post‑discharge planning, and PIN reimburses the coordination needed to address barriers like food insecurity or transportation gaps. By embedding these codes into daily workflows, practices can capture revenue for activities that already improve patient experience, such as weekly check‑ins, medication reconciliation, and community resource referrals. The data generated from these interactions also builds a performance narrative that can be presented to payers and accountable care organizations, demonstrating readiness for larger value‑based contracts.

For oncology leaders, the strategic advantage lies in the scalability of these models. Small, purposeful steps—like enrolling a patient in Meals on Wheels or arranging transport through PIN—create measurable outcomes that reduce emergency department visits, which account for over half of preventable cancer‑related admissions. As practices refine their infrastructure, they not only enhance clinical quality but also generate a portfolio of reimbursable services that mitigates financial exposure. This incremental approach positions community oncology to transition smoothly into full‑scale value‑based arrangements, ensuring sustainable growth in a rapidly evolving reimbursement landscape.